Abstract
To investigate the involvement of systemic oxidative stress in the pathogenesis of murine cerebral malaria, mice were infected with the Plasmodium berghei (P. berghei) ANKA 6653 strain. Serum tryptophan (Trp), kynurenine and urinary biopterin, liver, brain, spleen and serum superoxide dismutase (SOD), glutathione peroxidase (GPx), malondialdehyde (MDA) and nitrite and nitrate (NOx) levels were measured on day 7 post-inoculation. Our data showed a significant decrease in SOD and an increase in GPx activity and MDA level in all the examined biological materials (p<0.05), except spleen. Conversely, GPx activities in spleen were depleted, while SOD and MDA levels remained unchanged. Increased MDA levels might indicate increased peroxynitrite production, lipid peroxidation and oxidative stress. Also, elevated urinary biopterin, which was accompanied by increased NOx (p<0.05), may support the inhibition of Trp degradation (p>0.05). The excessive NO synthesis in P. berghei infection may be related to the up-regulation of inducible NO synthase, which was in accordance with the increased biopterin excretion. Thus, the large quantities of released toxic redox active radicals attack cell membranes and induce lipid peroxidation. Although P. berghei infection did not demonstrate systemic Trp degradation and related indoleamine-2,3-dioxygenase activity, it may cause multi-organ failure and death, owing to host-derived severe oxidative stress.
Introduction
Malaria infection due to Plasmodium falciparum (P. falciparum) remains a devastating health problem all over the world, with an estimated 300–500 million cases occurring annually that lead to 1.5–3 million deaths [1]. Plasmodium berghei ANKA (P. berghei ANKA) infection is one of the best available mouse models for human P. falciparum-mediated cerebral malaria, which kills nearly 2.5 million people every year because of destructive neurological syndrome [2]. Indeed, infection with P. berghei ANKA, a rodent malarial parasite, produces a disease that closely mimics the features of malarial infection in man and induces neurological symptoms [3]. Despite the innate and adaptive immune response of the host against malarial infection, Plasmodium spp. causes the worst parasitic diseases in humans and evades host immunity in complicated ways [4].
It is thought that two factors are mainly responsible for the inability of the host to resist malarial infection. First, the parasite can escape from host immunity by antigenic variation, via its capacity to continuously alter the surface-exposed antigenic proteins that are vulnerable to antibody recognition and attack [5]. Actually, antigenic variation at the Plasmodium-infected erythrocyte surface plays a critical role in malaria disease severity and host immune evasion. Small variant gene families comprising the “Plasmodium interspersed repeat (pir) multigene gene family” of P. vivax, P. knowlesi and the rodent malarial types P. chabaudi, P. berghei and P. yoelii also show the same features, suggesting a role in antigenic variation and immune evasion [6]. Second, inappropriate immune activation following P. berghei ANKA infection might be due to the activation and expansion of T cells. The immune escape of malarial parasites requires the activation of regulatory T cells (Tregs) [7]. Furthermore, Walther et al. [8] found that up-regulation of Tregs correlates with rapid parasite growth during human malarial infection. Consequently, T-cell immune responses are critical for the protection of the host and for disease pathogenesis during infection with Plasmodium species [9].
Moreover, enhanced catabolism of tryptophan (Trp) is proposed as a sequential defense mechanism for the immune response against invading cells [10]. In this respect, interferon-γ (IFN-γ)-induced indoleamine 2,3-dioxygenase (IDO) activity and its antimicrobial effect may be taken into consideration. However, Villegas-Mendez et al. [11] showed that IFN-γ is not required for the activation of splenic CD4+ and CD8+T cells during P. berghei ANKA infection, but that it is essential for the contraction of the splenic effector T-cell population through the induction of apoptosis. Actually, IDO is the first and rate-limiting enzyme of the l-tryptophan-l-kynurenine (Kyn) pathway and IDO-mediated Trp depletion has a predominantly antimicrobial effect during the early phase of infection [12]. Although similar amounts of plasma, brain and spleen Trp concentrations were found in P. berghei ANKA-uninfected subjects, non-cerebral malarial and cerebral malarial (CM) groups, Sanni et al. [9] suggested that IDO expression in the brain has been implicated in the late-stage immunopathology of CM. IDO inhibition slightly suppresses parasite density in association with enhanced proliferation of CD4+ T cells in response to malarial parasites, but its biological significance remains unclear [4].
In addition, host immune response to malaria also involves phagocytosis as well as production of nitric oxide (NO) and oxygen radicals that form part of the host defense system and also contribute to the pathology of the disease. In this context, hemoglobin degradation by malarial parasites produces redox active by-products–free heme, superoxide and hydrogen peroxide (H2O2)–that enhance lipid peroxidation and confer oxidative insult on the host cells [13]. Since activation of IDO-mediated Trp metabolism is strongly redox sensitive [14], the present study was designed to investigate whether the dependence of systemic Trp degradation and concomitant oxidative stress increases the susceptibility to P. berghei ANKA 6653 strain parasitemia or not, on day 7 post-inoculation.
Materials and methods
In this study, six male Swiss Albino mice aged between 14 and 16 weeks were used to determine the oxidative stress response and Trp degradation profile in a murine malarial model. The mice were infected with the P. berghei ANKA 6653 strain. The control group also consisted of eight male mice with the same characteristics [mean±standard error of the mean (SEM): 44.90±1.33 g]. All experimental procedures on mice were consistent with the International Guiding Principle for Biomedical Research Involving Animals, and our research plan was approved by the Local Ethics Committee for Experiments on Animals of Gazi University. To create the malarial infection model, 4.8×105 parasites were injected intraperitoneally into each mouse in the study group. The course of infection was followed by a daily determination of parasitemia by Giemsa-stained blood smear. When the parasitemia reached approximately 5% of the initial inoculation (at the onset of the CM syndrome), treatment groups were assigned. Seven days after the injection, blood samples were obtained from the tail veins of the mice and Giemsa-stained thin layer preparations were made. The preparations were evaluated microscopically for parasitemia. Malarial infection was confirmed clinically, as well as microscopically (data not shown). The liver, spleen and brain tissue samples and serum samples were kept at –80°C until evaluation.
As markers of oxidative stress in tissue and serum samples, the levels of NOx (the stable end products of NO) and the levels of malondialdehyde (MDA; the end product of lipid peroxidation) were studied. In addition, to determine the antioxidant response in the tissues and serum, superoxide dismutase (SOD) and glutathione peroxidase (GPx) enzyme activities were evaluated.
To determine the serum MDA levels (nmol/mL), the quantity of thiobarbituric acid reactive substances (TBARS) in the serum samples as an index of MDA production and hence lipid peroxidation was determined by the method described by Yoshioka et al. [15]. The standard MDA levels were expressed as nanomoles per milliliter (nmol/mL). The levels of TBARS were determined in tissue samples homogenized at a ratio of 1:10 (w/v) in 1.5% (w/v) cold potassium chloride solution by a thiobarbituric acid method, and the results were obtained in nanomoles per gram (nmol/g) of tissue weight by the method described by Mihara and Uchiyama [16].
NOx (μmol/mL) levels were determined according to the principle of Griess reaction [17]. SOD activity was determined using an SOD assay kit (Cayman Chemical, Ann Arbor, MI, USA). This kit uses a tetrazolium salt to detect the superoxide radicals generated by xanthine oxidase and hypoxanthine. One unit of SOD was defined as an amount of enzyme needed to exhibit 50% dismutation of the superoxide radical [18]. GPx activity was determined using a GPx assay kit (Cayman Chemical). This kit measures GPx activity indirectly by a coupled reaction with glutathione reductase [19].
Cardiac blood samples and urine samples of the control and the P. berghei ANKA-infected mice were collected to detect urinary biopterin, serum Trp and Kyn levels, and then the samples were stored at –80°C until the analysis. The biopterin and creatinine levels in the urine samples were analyzed by high-performance liquid chromatography (HPLC) [20]. The Trp and Kyn concentrations in serum were determined by reversed-phase HPLC. In order to estimate the Trp degradation, Kyn-to-Trp ratio (Kyn/Trp) was calculated by dividing the Kyn concentration (μmol/L) by the Trp concentration (mmol/L) [21].
Statistical analysis
Data were analyzed using the SPSS statistical package version 13.0 (SPSS Inc., Chicago, IL, USA). All results were expressed as the mean±SEM. After checking the data using the Kolmogorov-Smirnov test, we compared the non-parametric data of the two independent groups using the Mann-Whitney U-test, with a p-value of <0.05 considered statistically significant. Correlations were assessed using Spearman’s rank test.
Results
On the seventh day, malarial infection was confirmed clinically, as well as microscopically (data not shown). The liver and spleen of the infected mice (1.52±0.06 g and 0.09±0.01 g, respectively) were significantly heavier than those of the control group (2.24±0.15 g and 0.54±0.10 g, respectively) (p<0.05), confirming the pathological changes, while the overall weight of the study group (31.67±1.08 g) was significantly lower than the that of the healthy control group (44.90±1.33 g) (p<0.05). Parasitemia was also detected in the erythrocytes and brain of the infected mice. In the P. berghei ANKA-infected mice, neither the serum Trp nor the Kyn concentration was different compared to the control group (p>0.05). Despite the unchanged Kyn/Trp, urinary biopterin excretion, the oxidized tetrahydrobiopterin product, significantly increased to 1710.78±213.91 μmol biopterin/mol creatinine in the infected mice compared to the control group: 777.49±102.98 μmol biopterin/mol creatinine (p<0.05) (Table 1). This increase in the excretion of biopterin was consistent with the elevated levels of NOx, as tetrahydrobiopterin is the cofactor of NO synthase. The infection caused a significant rise in the serum, liver, spleen and brain NOx concentrations (2.65±0.22 μmol/mL, 42.61±5.84 μmol/mL, 27.25±1.57 μmol/mL and 39.58±4.37 μmol/mL, respectively) when compared with the matched control group (0.78±0.08 μmol/mL, 20.44±1.51 μmol/mL, 16.47±1.65 μmol/mL and 13.63±2.67 μmol/mL, respectively) (p<0.05) (Figure 1). However, we could not observe a correlation between urinary biopterin levels and serum Kyn/Trp in either the P. berghei ANKA-infected group or the healthy mice (p>0.05). Malarial infection caused a significant increase in the MDA lipid peroxidation marker and GPx in the liver, brain and serum (MDA: 12.40±0.86 nmol/g, 19.60±2.44 nmol/g and 24.40±3.07 nmol/mL, respectively; GPx: 155.01±14.41 U/mL, 373.97±19.45 U/mL and 20.51±1.10 U/mL, respectively) of the infected mice (p<0.05) and a decrease in SOD levels (0.71±0.04 U/mL, 4.42±0.23 U/mL and 0.25±0.004 U/mL, respectively) compared to the control group (MDA: 1.86±0.26 nmol/g, 7.00±1.23 nmol/g and 11.43±1.32 nmol/mL; GPx: 78.89±4.37 U/mL, 216.11±24.42 U/mL and 5.04±0.80 U/mL; SOD: 1.04±0.04 U/mL, 10.94±5.34 U/mL and 0.44±0.02 U/mL, respectively) (p<0.05) (Figures 2–4). Moreover, the levels of SOD and MDA in the spleen remained unchanged compared to the control group (p>0.05). Despite the increased activity of GPx in the other organs, spleen GPx was significantly decreased in the infected group (p<0.05).
Comparison between urinary biopterin, serum tryptophan and kynurenine levels of the control group and P. berghei ANKA-infected mice.
| Control group (n=10) | Plasmodium berghei ANKA-infected group (n=10) | p-Value | |
|---|---|---|---|
| Micromoles of biopterin/mole of creatinine | 777.49±102.98 | 1710.78±213.91 | 0.002* |
| Tryptophan (μmol/L) | 38.96±1.11 | 38.79±2.49 | 1.000 |
| Kynurenine (μmol/L) | 1.75±0.12 | 1.76±0.13 | 1.000 |
| Kynurenine/tryptophan (μmol/mmol) | 45.52±3.43 | 47.43±4.13 | 0.879 |
*p<0.05; statistically significant.

Comparison between the nitric oxide (NOx) levels of the control group and the P. berghei ANKA-infected mice.

Comparison between the malondialdehyde (MDA) levels of the control group and the P. berghei ANKA-infected mice.

Comparison between the glutathione peroxidase (GP) levels of the control group and the P. berghei ANKA-infected mice.

Comparison between the superoxide dismutase (SOD) levels of the control group and the P. berghei ANKA-infected mice.
Discussion
Despite the known pathologies in the tissues, the precise mechanism leading to severe distress in CM is poorly understood.
Because of the life cycle of malarial parasite, infection of red blood cells with Plasmodium subjects them to oxidative stress. Hemoglobin degradation by malarial parasite of the infected cells produces a superoxide, H2O2, that enhances lipid peroxidation and activates host cell hexose monophosphate shunt. This stress is sustained during the digestion of host cell hemoglobin by the parasite [22]. It has been recently shown that de novo synthesis of GSH is not essential for the survival of the blood stages of the rodent malarial parasite, P. berghei ANKA [23]. Eventually, erythrocyte defense mechanisms, namely, SOD, catalase, GPx, nicotinamide adenine dinucleotide phosphate (NADPH), nicotinamide adenine dinucleotide, reduced glutathione (GSH) and glutathione reductase, are depleted in the host owing to the infection [24]. Therefore, efficient antioxidant and redox systems are required to protect the cells from the parasites’ oxidative damage caused by reactive oxygen species (ROS). Furthermore, intraerythrocytic malarial parasites also impose an oxidative stress on their host cells.
In our study, the liver, brain and serum of P. berghei ANKA-infected mice showed significantly higher GPx concentrations in comparison to those of the control group. GPx catalyzes the reduction of H2O2 by two molecules of GSH as part of the defense system against ROS. Consequently, GSH is converted into oxidized glutathione during the elimination of H2O2 and of lipid peroxides by the activity of GPx [25]. Considering the relative contributions of catalase and GPx to the elimination of H2O2, Cohen and Hochstein [26] stated that GPx is the major route for H2O2 breakdown under physiological conditions. However, at higher concentrations of H2O2, the action of catalase becomes increasingly important [26]. Nevertheless, Gaetani et al. [25] demonstrated that catalase and GPx are equally involved in the removal of H2O2 in human erythrocytes. However, failure of only one of the two mechanisms for disposing H2O2 may not be deleterious for the host [27]. When the erythrocyte is under peroxidative stress, the cell enhances its ability to destroy H2O2 through the NADPH-dependent glutathione reductase/GPx system [28]. During the blood stages of malarial parasites, the parasites endocytose large quantities of the surrounding erythrocyte cytoplasm and deliver them to a digestive food vacuole via vesicles [29]. If the uptake of GSH into the endocytic vesicles is followed by the transport into the parasite’s cytoplasm, the parasite might use the host GSH for its own GSH metabolism. In this case, despite the high GPx activity, the host cannot overcome the oxidative stress because of the depletion of the available GSH of the host cells.
When the increase in GPx activity is accompanied by an adequate amount of SOD, dismutation of ROS by SOD generates peroxides, which are further reduced to lipid peroxides by GPx [30]. SOD catalyzes the oxidation/reduction conversion of superoxide radicals to H2O2. GPx converts H2O2 into water [31]. Plasmodium berghei ANKA lacks endogenous SOD; instead, it appears to take up and concentrate SOD from its host erythrocytes. Thus the adopted host enzyme is localized inside the lysosomes [32]. Actually, P. berghei ANKA in mice was found to derive a substantial amount of SOD from the host cell cytoplasm. It is evident that plasmodia isolated from mouse red cells contain a mouse type of SOD [33]. Linares et al. [34] reported that the functional failure of the host’s antioxidant defense system at the level of SOD is associated with the reduced expression of the transcription factors of the redox status in the host brain. The authors also indicated that hsp70, which is a regulator of the SOD-1 and SOD-2 enzymes, is down-regulated during the course of CM [34]. Thus, in our study, reduced tissue and serum SOD concentrations might be related to the transcriptional inhibition of the SOD enzyme activity. Also, P. berghei ANKA might have taken up a large amount of the SOD enzyme from its host cells. Therefore, inadequate levels of SOD might lead to excessive superoxide radical availability.
Nevertheless, the significant increase in the levels of MDA in the serum and tissues (liver and brain) of our P. berghei ANKA-infected mice indicated an extensive lipid peroxidation due to inadequate host antioxidant capacity [35]. The higher levels of NOx in the liver, spleen and brain as well as in the serum of P. berghei ANKA-infected mice confirmed the systemic effect of NO.
Actually, the induction of inducible nitric oxide synthase (iNOS) and the subsequent biological actions of NO are complex. The net effect of NO depends on its available concentrations in body fluids, target cell type and interactions with ROS [36]. Therefore, the amount of serum NO availability most probably might be due to the formation of peroxynitrite and other reactive nitrogen species (RNS), nitrite-NO pathway, rather than to the iNOS expression rate of inflammatory cells. Regarding the confirmation of oxidative stress, actual plasma NO concentrations are more important indicators than iNOS expression [37]. In this study, the eventual higher NOx and MDA levels in the liver and brain tissues of P. berghei ANKA-infected mice may also be an indicator of multiple organ failure. Gramaglia et al. [38] indicated that exogenously given NO inactivates NO-scavenging free hemoglobin in the plasma and restores nitrite to the concentrations observed in uninfected mice; therefore they concluded that low rather than high NO bioavailability contributes to the genesis of experimental cerebral malaria.
Activation of macrophages and subsequent development of strong pro-inflammatory immune responses are key events in the pathogenesis of severe CM in mice [39]. Couper et al. [40] showed that parasitized red blood cell-derived microparticles as a major inducer of systemic inflammation during malarial infection can stimulate tumor necrosis factor (TNF)-α production by macrophages. Microparticles derived from P. berghei ANKA-infected TNF-α-/- and IFN-γ-/- mice promote the up-regulation of TNF-α production more than live infected red blood cells [40]. TNF-α is apparently required for P. berghei ANKA-induced NO up-regulation and subsequent pathology resulting in fatal CM. In the absence of TNF-α, endothelial intercellular adhesion molecule-1 expression as well as the systemic release of NO is reduced, and P. berghei ANKA infection fails to cause fatal cerebral malaria [41].
Cross-regulation between iNOS and IDO is important for the functions of the host cell and may also prevent the accumulation of potentially toxic metabolites in the Trp degradation pathway [42]. In fact, IDO induction converts Trp to N-formylkynurenine and results in Trp depletion. Consequently, Trp depletion causes the inhibition of parasite growth. Actually, the expression of iNOS or IDO appears to depend on the cell type or tissue. IDO activity is characterized best by the Kyn-Trp ratio, which correlates with concentrations of immune activation markers such as neopterin or tetrahydrobiopterin [43]. In contrast to the findings of Medana et al., our study we did not observe any alteration in serum Kyn-Trp ratio in comparison to the control group, nor did find any significant correlation between urinary biopterin level and the serum Kyn/Trp of P. berghei ANKA-infected mice [44]. In the mononuclear cells of infected mice, it was not neopterin but high concentration of biopterin that was found [45]. The correlation between amount of bound tetrahydrobiopterin and NOS activity clearly suggests that tetrahydrobiopterin is an essential cofactor of the enzyme. Basal tetrahydrobiopterin synthesis appears to be adequate to support iNOS activity [46]. However, when the tetrahydrobiopterin is oxidized, it leads to the increased formation of oxygen-derived radicals instead of NO by decoupled NOS [47]. Therefore, in our study, higher available NO concentration and its inhibitor effect on IDO activity should be taken into consideration in P. berghei ANKA-infected mice. The cofactor tetrahydrobiopterin is required for normal NOS function, but it is highly sensitive to oxidant stress. The decrease in iNOS activity induced by the superoxide is almost complete owing to tetrahydrobiopterin oxidation [48]. Although tetrahydrobiopterin is essential for NO production from iNOS, elevated tetrahydrobiopterin, or its oxidized product biopterin, above the basal level is not needed for excess NO synthesis [49]. Thus, our data demonstrated that oxidation of tetrahydrobiopterin is not the major mechanism of oxidative stress-induced iNOS inhibition and that iNOS induction is not associated with an IFN-γ-mediated mechanism. Mostly in murine fibroblasts, TNF-α induces guanosine triphosphate (GTP) cyclohydrolase I activity up to 30-fold, thus potentiating the biosynthesis of tetrahydrobiopterin [50]. Another difference to the human system is that murine macrophages already contain high GTP-cyclohydrolase I activities even in unstimulated conditions. This gives an enzymatic basis for the high intracellular tetrahydrobiopterin concentrations in murine macrophage cell lines [45, 51, 52]. Both exogenous and endogenous NO inhibit IDO activity and oxidative arginine and Trp metabolism in IFN γ-primed mononuclear phagocytes. However, induction of IDO activity was observed in murine macrophages when the synthesis of RNS was inhibited [53]. In our study, the urinary biopterin concentrations of mice 7 days after the inoculation of P. berghei ANKA were found to be 120% higher than those of the control animals, indicating a significant increase in tetrahydrobiopterin synthesis. The corresponding increase in serum NOx levels was 239% compared to the healthy mice. Excess NOx production may induce the formation of RNSs, which are harmful for the host.
Although the spleen is rich in macrophages and malarial infection is hematogenous in nature, splenic IDO activity was unchanged in non-CM mice and only minimally elevated in CM mice. This apparent resistance of the spleen to IDO induction may be attributed to the up-regulation of iNOS. Spleen iNOS is significantly increased in malarial infection [54]. The combination of IFN-γ and TNF-α synergizes to induce NOx synthesis in the macrophages [55]. The spleen is considered as the major site of parasite removal and splenic function is increased in acute malaria; the clearance thresholds for both mechanical filtration and Fc receptor-mediated parasitized erythrocyte clearance are lowered [56, 57]. The spleen normally removes residual host nuclear materials from erythrocytes, but how it recognizes damaged intraerythrocytic parasites is not known [58]. The spleen of non-CM patients has more phagocytes than that of CM patients. This observation reveals that the spleen plays a major role in malarial parasite clearance and is associated with host defense mechanisms against malaria [59]. The adhesion of parasitized red blood cells to spleen endothelial cells induces caspase activation, oxidative stress and apoptosis [60]. Superoxide anions can form peroxynitrites in association with NO. Parasitized red blood cell-induced apoptosis in endothelial cells is mediated through an oxidative stress pathway [61]. Under peroxidative stress, unchanged SOD level and significantly decreased GPx activity of the spleen in infected mice decrease the ability of the cell to destroy H2O2 through the NADPH-dependent glutathione reductase/GPx system [29]. Thus, in our study, probable diminution of GSH and related inappropriate amount of GPx could not provide a protective effect against the oxidative damage of H2O2.
NO inhibits IDO activity in the macrophages. Thus Sanni et al. [9] found significant increases in splenic Trp concentration above that of control mice in CM mice, as well as in non-CM mice, but plasma Trp concentrations were similar in all groups. However, we could not measure either the high IDO activity or the excessive Trp degradation products in the serum samples 7 days after the injection. Results of this study revealed that P. berghei ANKA parasitemia did not affect the serum Trp levels and IDO activity despite the high amount of biopterin on the seventh day. Our findings are in agreement with the previous observations of Nie et al. [62], who supported the notion that IFN-γ does not seem to play a major role in the control of parasite growth in the P. berghei ANKA rodent model of CM.
In conclusion, a large amount of NO released from several cellular sources seems to be ineffective against intracellular parasite clearance. Thus, P. berghei ANKA may cause multi-organ failure and death owing to host-derived severe oxidative stress and inadequate macrophage response on the seventh day. Further studies should focus on the role of NO in cell-mediated immunity and in the interaction with murine malaria.
Acknowledgments
We are thankful to the director and the staff of Gazi University Laboratory Animal Breeding and Experimental Research Center for their excellent technical assistance.
Conflict of interest statement: There is no conflict of interest.
References
1. Rodrigues JR, Gamboa ND. Effect of dequalinium on the oxidative stress in Plasmodium berghei-infected erythrocytes. Parasitol Res 2009;104:1491–6.10.1007/s00436-009-1355-7Search in Google Scholar PubMed
2. Nie CQ, Bernard NJ, Schofield L, Hansen DS. CD4+ CD25+ regulatory T cells suppress CD4+ T-cell function and inhibit the development of Plasmodium berghei-specific TH1 responses involved in cerebral malaria pathogenesis. Infect Immun 2007;75:2275–82.10.1128/IAI.01783-06Search in Google Scholar PubMed PubMed Central
3. Cunha-Rodrigues M, Portugal S, Febbraio M, Mota MM. Infection by and protective immune responses against Plasmodium berghei ANKA are not affected in macrophage scavenger receptors a deficient mice. BMC Microbiol 2006;6:1–5.10.1186/1471-2180-6-73Search in Google Scholar PubMed PubMed Central
4. Tetsutani K, To H, Torii M, Hisaeda H, Himeno K. Malaria parasite induces tryptophan-related immune suppression in mice. Parasitology 2007;134:923–30.10.1017/S0031182007002326Search in Google Scholar PubMed
5. Dzikowski R, Deitsch KW. Genetics of antigenic variation in Plasmodium falciparum. Curr Genet 2009;55:103–10.10.1007/s00294-009-0233-2Search in Google Scholar PubMed PubMed Central
6. Cunningham D, Lawton J, Jarra W, Preiser P, Langhorne J. The pir multigene family of Plasmodium: antigenic variation and beyond. Mol Biochem Parasitol 2010;170:65–73.10.1016/j.molbiopara.2009.12.010Search in Google Scholar PubMed
7. Hisaeda H, Maekawa Y, Iwakawa D, Okada H, Himeno Kishihara K, Tsukumo SI, et al. Escape of malaria parasites from host immunity requires CD4 CD25 regulatory T cells Nat Med 2004;10:29–30.10.1038/nm975Search in Google Scholar PubMed
8. Walther M, Tongren JE, Andrews L, Korbel D, King E, Fletcher H, et al. Upregulation of TGF-, FOXP3, and CD4 CD25 regulatory T cells correlates with more rapid parasite growth in human malaria infection. Immunity 2005;23:287–96.10.1016/j.immuni.2005.08.006Search in Google Scholar PubMed
9. Sanni LA, Thomas SR, Tattam BN, Moore DE, Chaudhri G, Stocker R, et al. Dramatic changes in oxidative tryptophan metabolism along the kynurenine pathway in experimental cerebral and non-cerebral malaria. Am J Pathol 1998;152:611–9.Search in Google Scholar
10. Thomas SR, Stocker R. Redox reactions related to indoleamine 2,3-dioxygenase and tryptophan metabolism along the kynurenine pathway. Redox Rep 1999;4:199–220.10.1179/135100099101534927Search in Google Scholar PubMed
11. Villegas-Mendez A, de Souza JB, Murungi L, Hafalla JC, Shaw TN, Greig R, et al. Heterogeneous and tissue-specific regulation of effector T cell responses by IFN-gamma during Plasmodium berghei ANKA infection. J Immunol 2011;187:2885–97.10.4049/jimmunol.1100241Search in Google Scholar PubMed PubMed Central
12. Müller A, Heseler K, Schmidt SK, Spekker K, Mackenzie CR, Däubener W. The missing link between indoleamine 2,3-dioxygenase mediated antibacterial and immunoregulatory effects. J Cell Mol Med 2009;13:1125–35.10.1111/j.1582-4934.2008.00542.xSearch in Google Scholar
13. Becker K, Tilley L, Vennerstrom JL, Roberts D, Rogerson S, Ginsburg H. Oxidative stress in malaria parasite-infected erythrocytes: host-parasite interactions. Int J Parasitol 2004;34:163–89.10.1016/j.ijpara.2003.09.011Search in Google Scholar
14. Gostner JM, Becker K, Ueberall F, Fuchs D. The good and bad of antioxidant foods: an immunological perspective. Food Chem Toxicol 2015;80:72–9. pii: S0278-6915(15)00058-7.10.1016/j.fct.2015.02.012Search in Google Scholar
15. Yoshioka T, Kawada K, Shimada T, Mori M. Lipid peroxidation in maternal and cord blood and protective mechanism against activated-oxygen toxicity in the blood. Am J Obstet Gynecol 1979;135:372–6.10.1016/0002-9378(79)90708-7Search in Google Scholar
16. Mihara M, Uchiyama M. Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Ann Biochem 1978;86:271–8.10.1016/0003-2697(78)90342-1Search in Google Scholar
17. Moncada S. The 1991 Ulf von Euler lecture. The L-arginine: nitric oxide pathway. Acta Physiol Scand 1992;145:201–27.10.1111/j.1748-1716.1992.tb09359.xSearch in Google Scholar PubMed
18. Marklund S. Distribution of CuZn superoxide dismutase and Mn superoxide dismutase in human tissues and extracellular fluids. Acta Physiol Scand (Suppl) 1980;492:19–23.Search in Google Scholar
19. Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 1967;70:158–69.Search in Google Scholar
20. Engin AB, Ergun MA, Yurtcu E, Kan D, Sahin G. Effect of ionizing radiation on the pteridine metabolic pathway and evaluation of its cytotoxicity in exposed hospital staff. Mutat Res 2005;585:184–92.10.1016/j.mrgentox.2005.05.005Search in Google Scholar PubMed
21. Brandacher G, Perathoner A, Ladurner R, Schneeberger S, Obrist P, Winkler C, et al. Prognostic value of indoleamine 2,3-dioxygenase expression in colorectal cancer: effect on tumor-infiltrating T cells. Clin Cancer Res 2006;12:1144–51.10.1158/1078-0432.CCR-05-1966Search in Google Scholar PubMed
22. Ginsburg H, Atamna H. The redox status of malaria-infected erythrocytes: an overview with an emphasis on unresolved problems. Parasite 1994;1:5–13.10.1051/parasite/1994011005Search in Google Scholar PubMed
23. Vega-Rodríguez J, Franke-Fayard B, Dinglasan RR, Janse CJ, Pastrana-Mena R, Waters AP, et al. The glutathione biosynthetic pathway of Plasmodium is essential for mosquito transmission. PLOS Pathog 2009;5:e1000302.10.1371/journal.ppat.1000302Search in Google Scholar PubMed PubMed Central
24. Mishra NC, Kabilan L, Sharma A. Oxidative stress and malaria-infected erythrocytes. Indian J Malariol 1994;31:77–87.Search in Google Scholar
25. Gaetani GF, Galiano S, Canepa L, Ferraris AM, Kirkman HN. Catalase and glutathione peroxidase are equally active in detoxification of hydrogen peroxide in human erythrocytes. Blood 1989;73:334–9.10.1182/blood.V73.1.334.334Search in Google Scholar
26. Cohen G, Hochstein P. Glutathione peroxidase: the primary agent for the elimination of hydrogen peroxide in erythrocytes. Biochemistry 1963;2:1420–8.10.1021/bi00906a038Search in Google Scholar
27. Scott MD, Lubin BH, Zuo L, Kuypers FA. Erythrocyte defense against hydrogen peroxide: preeminent importance of catalase. J Lab Clin Med 1991;118:7–16.Search in Google Scholar
28. Kirkman HN, Gaetani GF. Catalase: a tetrameric enzyme with four tightly bound molecules of NADPH. Proc Natl Acad Sci USA 1984;81:4343–7.10.1073/pnas.81.14.4343Search in Google Scholar
29. Abu Bakar N, Klonis N, Hanssen E, Chan C, Tilley L. Digestive-vacuole genesis and endocytic processes in the early intraerythrocytic stages of Plasmodium falciparum. J Cell Sci 2010;123:441–50.10.1242/jcs.061499Search in Google Scholar
30. Michiels C, Raes M, Toussaint O, Remacle J. Importance of Se-glutathione peroxidase, catalase, and Cu/Zn-SOD for cell survival against oxidative stress. Free Radic Biol Med 1994;17:235–48.10.1016/0891-5849(94)90079-5Search in Google Scholar
31. Li S, Yan T, Yang JQ, Oberley TD, Oberley LW. The role of cellular glutathione peroxidase redox regulation in the suppression of tumor cell growth by manganese superoxide dismutase. Cancer Res 2000;60:3927–39.Search in Google Scholar
32. Fairfield AS, Eaton JW, Meshnick SR. Superoxide dismutase and catalase in the murine malaria, Plasmodium berghei: content and subcellular distribution. Arch Biochem Biophys 1986;250:526–9.10.1016/0003-9861(86)90758-7Search in Google Scholar
33. Fairfield AS, Meshnick SR, Eaton JW. Malaria parasites adopt host cell superoxide dismutase. Science 1983;221:764–6.10.1126/science.6348944Search in Google Scholar
34. Linares M, Marín-García P, Martínez-Chacón G, Pérez-Benavente S, Puyet A, Diez A, et al. Glutathione peroxidase contributes with heme oxygenase-1 to redox balance in mouse brain during the course of cerebral malaria. Biochim Biophys Acta 2013;1832:2009–18.10.1016/j.bbadis.2013.07.010Search in Google Scholar
35. Reis PA, Comim CM, Hermani F, Silva B, Barichello T, Portella AC, et al. Cognitive dysfunction is sustained after rescue therapy in experimental cerebral malaria, and is reduced by additive antioxidant therapy. PLOS Pathog 2010;6:e463.10.1371/journal.ppat.1000963Search in Google Scholar
36. Hofseth LJ, Hussain SP, Wogan GN, Harris CC. Nitric oxide in cancer and chemoprevention. Free Radic Biol Med 2003;34:955–68.10.1016/S0891-5849(02)01363-1Search in Google Scholar
37. Lee AK, Sung SH, Kim YC, Kim SG. Inhibition of lipopolysaccharide-inducible nitric oxide synthase, TNF-alpha and COX-2 expression by sauchinone effects on I-kappaBalpha phosphorylation, C/EBP and AP-1 activation. Br J Pharmacol 2003;139:11–20.10.1038/sj.bjp.0705231Search in Google Scholar PubMed PubMed Central
38. Gramaglia I, Sobolewski P, Meays D, Contreras R, Nolan JP, Frangos JA, et al. Low nitric oxide bioavailability contributes to the genesis of experimental cerebral malaria. Nat Med 2006;12:1417–22.10.1038/nm1499Search in Google Scholar PubMed
39. Pais TF, Chatterjee S. Brain macrophage activation in murine cerebral malaria precedes accumulation of leukocytes and CD8+T cell proliferation. J Neuroimmunol 2005;163:73–83.10.1016/j.jneuroim.2005.02.009Search in Google Scholar PubMed
40. Couper KN, Barnes T, Hafalla JC, Combes V, Ryffel B, Secher T, et al. Parasite-derived plasma microparticles contribute significantly to malaria infection-induced inflammation through potent macrophage stimulation. PLOS Pathog 2010;6:e1000744.10.1371/journal.ppat.1000744Search in Google Scholar PubMed PubMed Central
41. Rudin W, Eugster HP, Bordmann G, Bonato J, Müller M, Yamage M, et al. Resistance to cerebral malaria in tumor necrosis factor-alpha/beta-deficient mice is associated with a reduction of intercellular adhesion molecule-1 up-regulation and T helper type 1 response. Am J Pathol 1997;150:257–66.Search in Google Scholar
42. Fujigaki S, Saito K, Takemura M, Maekawa N, Yamada Y, Wada H, et al. L-tryptophan-L-kynurenine pathway metabolism accelerated by Toxoplasma gondii infection is abolished in gamma interferon-gene-deficient mice: cross-regulation between inducible nitric oxide synthase and indoleamine-2,3-dioxygenase. Infect Immun 2002;70:779–86.10.1128/IAI.70.2.779-786.2002Search in Google Scholar PubMed PubMed Central
43. Schröcksnadel K, Wirleitner B, Winkler C, Fuchs D. Monitoring tryptophan metabolism in chronic immune activation. Clin Chim Acta 2006;364:82–90.10.1016/j.cca.2005.06.013Search in Google Scholar PubMed
44. Medana IM, Day NP, Salahifar-Sabet H, Stocker R, Smythe G, Bwanaisa L, et al. Metabolites of the kynurenine pathway of tryptophan metabolism in the cerebrospinal fluid of Malawian children with malaria. J Infect Dis 2003;188:844–9.10.1086/377583Search in Google Scholar PubMed
45. Schoedon G, Troppmair J, Fontana A, Huber C, Curtius HC, Niederwieser A. Biosynthesis and metabolism of pterins in peripheral blood mononuclear cells and leukemia lines of man and mouse. Eur J Biochem 1987;166:303–10.10.1111/j.1432-1033.1987.tb13515.xSearch in Google Scholar PubMed
46. Thöny B, Auerbach G, Blau N. Tetrahydrobiopterin biosynthesis, regeneration and functions. Biochem J 2000;347:1–16.10.1042/bj3470001Search in Google Scholar
47. Werner ER, Blau N, Thöny B. Tetrahydrobiopterin: biochemistry and pathophysiology. Biochem J 2011;438:397–414.10.1042/BJ20110293Search in Google Scholar PubMed
48. Sun J, Druhan LJ, Zweier JL. Reactive oxygen and nitrogen species regulate inducible nitric oxide synthase function shifting the balance of nitric oxide and superoxide production. Arch Biochem Biophys 2010;494:130–7.10.1016/j.abb.2009.11.019Search in Google Scholar
49. Shimizu S, Ishii M, Kawakami Y, Kiuchi Y, Momose K, Yamamoto T. Presence of excess tetrahydrobiopterin during nitric oxide production from inducible nitric oxide synthase in LPS-treated rat aorta. Life Sci 1999;65:2769–79.10.1016/S0024-3205(99)00545-7Search in Google Scholar
50. Werner ER, Werner-Felmayer G, Fuchs D, Hausen A, Reibnegger G, Yim JJ, Wachter H. Impact of tumour necrosis factor-alpha and interferon-gamma on tetrahydrobiopterin synthesis in murine fibroblasts and macrophages. Biochem J 1991;280:709–14.10.1042/bj2800709Search in Google Scholar
51. Tayeh MA, Marletta MA. Macrophage oxidation of L-arginine to nitric oxide, nitrite, and nitrate. Tetrahydrobiopterin is required as a cofactor. J Biol Chem 1989;264:19654–8.10.1016/S0021-9258(19)47163-9Search in Google Scholar
52. Kwon NS, Nathan CF, Stuehr DJ. Reduced biopterin as a cofactor in the generation of nitrogen oxides by murine macrophages. J Biol Chem 1989;264:20496–501.10.1016/S0021-9258(19)47089-0Search in Google Scholar
53. Thomas SR, Mohr D, Stocker R. Nitric oxide inhibits indoleamine 2,3-dioxygenase activity in interferon-gamma primed mononuclear phagocytes. J Biol Chem 1994;269:14457–64.10.1016/S0021-9258(17)36645-0Search in Google Scholar
54. Jacobs P1, Radzioch D, Stevenson MM. Nitric oxide expression in the spleen, but not in the liver, correlates with resistance to blood-stage malaria in mice. J Immunol 1995;155: 5306–13.10.4049/jimmunol.155.11.5306Search in Google Scholar
55. Drapier JC, Wietzerbin J, Hibbs JB Jr. Interferon-gamma and tumor necrosis factor induce the L-arginine-dependent cytotoxic effector mechanism in murine macrophages. Eur J Immunol 1988;18:1587–92.10.1002/eji.1830181018Search in Google Scholar PubMed
56. Ho M, White NJ, Looareesuwan S, Wattanagoon Y, Lee SH, Walport MJ, et al. Splenic Fc receptor function in host defense and anemia in acute Plasmodium falciparum malaria. J Infect Dis 1990;161:555–61.10.1093/infdis/161.3.555Search in Google Scholar PubMed
57. Looareesuwan S, Ho M, Wattanagoon Y, White NJ, Warrell DA Bunnag D, et al. Dynamic alteration in splenic function during acute falciparum malaria. N Engl J Med 1987;317:675–9.10.1056/NEJM198709103171105Search in Google Scholar PubMed
58. Angus BJ, Chotivanich K, Udomsangpetch R, White NJ. In vivo removal of malaria parasites from red blood cells without their destruction in acute falciparum malaria. Blood 1997:90: 2037–40.10.1182/blood.V90.5.2037Search in Google Scholar
59. Prommano O, Chaisri U, Turner GD, Wilairatana P, Ferguson DJ, Viriyavejakul P, et al. A quantitative ultrastructural study of the liver and the spleen in fatal falciparum malaria. Southeast Asian J Trop Med Public Health 2005;36:1359–70.Search in Google Scholar
60. Taoufiq Z, Pino P, Dugas N, Conti M, Tefit M, Mazier D, et al. Transient supplementation of superoxide dismutase protects endothelial cells against Plasmodium falciparum-induced oxidative stress. Mol Biochem Parasitol 2006;150:166–73.10.1016/j.molbiopara.2006.07.008Search in Google Scholar PubMed
61. Pino P, Vouldoukis I, Dugas N, Hassani-Loppion G, Dugas B, Mazier D. Redox-dependent apoptosis in human endothelial cells after adhesion of Plasmodium falciparum-infected erythrocytes. Ann N Y Acad Sci 2003;1010:582–6.10.1196/annals.1299.109Search in Google Scholar PubMed
62. Nie CQ, Bernard NJ, Norman MU, Amante FH, Lundie RJ, Crabb BS, et al. IP-10-mediated T cell homing promotes cerebral inflammation over splenic immunity to malaria infection. PLOS Pathog 2009;5:e1000369.10.1371/journal.ppat.1000369Search in Google Scholar PubMed PubMed Central
©2015 by De Gruyter
This article is distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Articles in the same Issue
- Frontmatter
- Review
- Acetylenic antifolates as anticancer agents
- Original articles
- Neopterin and 7,8-dihydroneopterin are generated within atherosclerotic plaques
- Late-stage systemic immune effectors in Plasmodium berghei ANKA infection: biopterin and oxidative stress
- Conference abstracts
- 34th International Winter Workshop / Clinical, Chemical and Biochemical Aspects of Pteridines and Related Topics
Articles in the same Issue
- Frontmatter
- Review
- Acetylenic antifolates as anticancer agents
- Original articles
- Neopterin and 7,8-dihydroneopterin are generated within atherosclerotic plaques
- Late-stage systemic immune effectors in Plasmodium berghei ANKA infection: biopterin and oxidative stress
- Conference abstracts
- 34th International Winter Workshop / Clinical, Chemical and Biochemical Aspects of Pteridines and Related Topics